The ACE Scientific Core will provide support for the specialized immunological assays used by the two ACE projects, the Pilot Project, and potential clinical trials. Human and clinical research depends on reliable assays of valuable and often un-repeatable samples. Carefully-standardized methods are essential to ensure ,the quality of the rich datasets that can be generated by methods such as polychromatic flow cytometry. Thus a central Core focusing on the assay protocols helps to maintain comparability between different investigators, even in different institutions. The ACE Core works closely with the Rochester Human Immunology Center (RHIC), which develops and distributes expertise in cutting-edge immunological technologies. The RHIC develops new methods, polishes existing methods, and produces robust Standard Operating Protocols (SOPs) for many immunological assays. Close interactions with the RHIC ensure that the ACE Core has immediate access to new and improved RHIC methods, and conversely, that the RHIC is fully aware of method development that would benefit the autoimmunity research of the ACE Core. The ACE Core has acquired expertise in the following areas: polychromatic flow cytometry, using 11- and 18-color flow cytometers;staining panels for analysis of T cell cytokines, B cell and Treg subpopulations; gating strategies for many-parameter flow cytometry data;Elispot, Fluorispot and Cellspot assays for human antigen-specific cytokine- and antibody-secreting T and B cells;Functional human Treg and B cell helper assays;Multiplexed Luminex bead assays for detection of cytokines and other proteins;and centralized processing of clinical specimens in GLP conditions. The Core will support Project 1 with the development of flow cytometry panels for analysis of B cell subpopulations and cytokine production;and the large-scale analysis of flow cytometry data. Project 2 will be supported with the development and refinement of flow cytometric analysis of Treg populations;continued development of Treg suppressor assays;and the analysis of cytokine expression in mouse and human autoimmune effector T cell populations. The Pilot Project will be supported by flow cytometry analysis and B cell Elispots. The Core is available to support ACE Clinical Trials according to well-validated SOPs in all of these areas.
The identification of patterns of immunity during autoimmunity is critical for understanding the causes of these diseases, and for planning therapies. The Scientific Core develops and performs high-resolution assays for immune function to assist the research project and clinical trials of the ACE.
|Misra, Ravi S; Shah, Syed; Fowell, Deborah J et al. (2015) Preterm cord blood CD4âº T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4âº T cells in bronchopulmonary dysplasia. Hum Immunol 76:329-38|
|Chara, Luis; SÃ¡nchez-Atrio, Ana; PÃ©rez, Ana et al. (2015) The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis. J Transl Med 13:2|
|Adlowitz, Diana G; Barnard, Jennifer; Biear, Jamie N et al. (2015) Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One 10:e0128269|
|Halliley, Jessica L; Tipton, Christopher M; Liesveld, Jane et al. (2015) Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity 43:132-45|
|Wei, Chungwen; Jenks, Scott; Sanz, IÃ±aki (2015) Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther 17:46|
|Kobie, James J; Treanor, John J; Ritchlin, Christopher T (2014) Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest 43:606-15|
|Zhang, Hengwei; Hilton, Matthew J; Anolik, Jennifer H et al. (2014) NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-ÎºB. J Clin Invest 124:3200-14|
|Segal, Benjamin M (2014) Stage-specific immune dysregulation in multiple sclerosis. J Interferon Cytokine Res 34:633-40|
|Palanichamy, Arumugam; Bauer, Jason W; Yalavarthi, Srilakshmi et al. (2014) Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol 192:906-18|
|Roberts, Mustimbo E P; Kaminski, Denise; Jenks, Scott A et al. (2014) Primary SjÃ¶gren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells. Arthritis Rheumatol 66:2558-69|
Showing the most recent 10 out of 76 publications